MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

MK-0773

CAS No. : 606101-58-0

MCE 站：MK-0773

产品活性：MK-0773 是一种选择性雄激素受体调节剂 (selective androgen receptor modulators)，与 AR 结合，IC₅₀ 值为 6.6 nM。

研究领域：Others

作用靶点：Androgen Receptor

In Vitro: The IC₅₀ of MK-0773 binding to AR is increased 3.5-fold in the presence of 25% rat serum and 13-fold in the presence of 25% human serum, indicating that it binds to serum proteins. The affinity of MK-0773 for AR across species is evaluated using COS cells transfected with AR, and IC₅₀ values are very similar in four species (rat, 0.50 nM; dog, 0.55 nM; rhesus, 0.45 nM; human, 0.65 nM).

In Vivo: MK-0773 (6 and 80 mg/kg, s.c.) produces exposure-related stimulatory effects on cortical BFR and LBM in the OVX rat model. MK-0773 (5, 15, and 80 mg/kg, s.c.) increases seminal vesicle weights, and has reduced effects on the prostate. The partial agonism and tissue selectivity of MK-0773 does not translate into differential effects on lipid metabolism in OVX rats.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Endocrinology Compound Library  |  DHEA  |  Medroxyprogesterone acetate  |  Bicalutamide  |  Flutamide  |  Spironolactone  |  Danazol  |  Testosterone propionate  |  Dimethylcurcumin  |  Epiandrosterone  |  Ailanthone  |  3,3'-Diindolylmethane  |  Clascoterone  |  Lupeol  |  Nilutamide  |  Cyproterone acetate  |  YK11  |  Stanolone benzoate  |  Triptophenolide  |  EPI-001  |  Adrenosterone  |  Dehydroisoandrosterone 3-acetate  |  PROTAC AR Degrader-4 TFA  |  11-Ketodihydrotestosterone  |  Boldenone Undecylenate  |  D4-abiraterone  |  Isosilybin B  |  Prochloraz  |  RU 58841  |  2,2,5,7,8-Pentamethyl-6-Chromanol

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。